News
Featured Articles
Nemera reinforces commitment to sustainability with first integrated ESG report
10/03/2023
Designed as a snapshot of work over the years and a look into the future, the first ESG report is a new and important step forward in our sustainability journey...
Continue ReadingThe Gender Equality Index at Nemera – Year 2022
28/02/2023
The Index, is calculated from 4 to 5 indicators depending on whether the company has less or more than 250 employees and takes into account
Continue ReadingReinforcing Diversity & Inclusion and ESG strategies!
14/02/2023
It is critical to partner with local organizations to ensure everyone in our society has an equal chance to benefit from work opportunities and succeed professionally.
Continue ReadingBrand new state-of-the-art Nemera manufacturing facility inaugurated in Poland
25/01/2023
Based in Szczecin, this facility will significantly boost Nemera’s manufacturing capabilities and bring more drug delivery device solutions to patients.
Continue ReadingA new ENT device: UniSpray
27/10/2021
We are happy to announce the launch of Unispray, our unidose system primarily for systemic-acting drug administration.
Continue ReadingNemera joins IPAC-RS as an Associate Member
20/10/2021
Nemera is excited to announce that it has become an Associate Member of the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS)
Continue Reading